99 related articles for article (PubMed ID: 17257899)
21. [An expression plasmid encoding recombinant immunotoxin IP10-DT390 suppresses the experimental autoimmune encephalomyelitis].
Chen W; Li H; Jia Y; Li M; Jiang Z; Lü M; Zhang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1118-22. PubMed ID: 18027709
[TBL] [Abstract][Full Text] [Related]
22. Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells.
Illés Z; Stern JN; Reddy J; Waldner H; Mycko MP; Brosnan CF; Ellmerich S; Altmann DM; Santambrogio L; Strominger JL; Kuchroo VK
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11749-54. PubMed ID: 15292513
[TBL] [Abstract][Full Text] [Related]
23. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
24. Regulation of encephalitogenic T cells with recombinant TCR ligands.
Burrows GG; Adlard KL; Bebo BF; Chang JW; Tenditnyy K; Vandenbark AA; Offner H
J Immunol; 2000 Jun; 164(12):6366-71. PubMed ID: 10843691
[TBL] [Abstract][Full Text] [Related]
25. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
26. Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide(91-110) and critical residues required for induction of EAE in HLA-DR3 transgenic mice.
Mangalam AK; Khare M; Krco CJ; Rodriguez M; David CS
J Neuroimmunol; 2005 Apr; 161(1-2):40-8. PubMed ID: 15748942
[TBL] [Abstract][Full Text] [Related]
27. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
[TBL] [Abstract][Full Text] [Related]
28. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
29. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor.
Greene MT; Ercolini AM; DeGutes M; Miller SD
J Autoimmun; 2008 Dec; 31(4):399-407. PubMed ID: 19008075
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Chen X; Hu X; Zou Y; Pi R; Liu M; Wang T; Zheng X; Liu M; Lin M; Liu P; Tao L
J Neuroimmunol; 2009 May; 210(1-2):22-9. PubMed ID: 19344957
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
[TBL] [Abstract][Full Text] [Related]
32. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
[TBL] [Abstract][Full Text] [Related]
33. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis.
Offner H; Polanczyk M
Ann N Y Acad Sci; 2006 Nov; 1089():343-72. PubMed ID: 17261780
[TBL] [Abstract][Full Text] [Related]
34. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
Allameh A; Maleklou N; Zargari M; Sanati MH
Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
[TBL] [Abstract][Full Text] [Related]
35. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.
Nalawade SA; Ji N; Raphael I; Pratt A; Kraig E; Forsthuber TG
Cell Immunol; 2018 Sep; 331():38-48. PubMed ID: 29789121
[TBL] [Abstract][Full Text] [Related]
36. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
37. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
38. Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
Sinha S; Miller L; Subramanian S; McCarty OJ; Proctor T; Meza-Romero R; Huan J; Burrows GG; Vandenbark AA; Offner H
J Neuroimmunol; 2010 Aug; 225(1-2):52-61. PubMed ID: 20546940
[TBL] [Abstract][Full Text] [Related]
39. RTL therapy for multiple sclerosis: a Phase I clinical study.
Offner H; Sinha S; Burrows GG; Ferro AJ; Vandenbark AA
J Neuroimmunol; 2011 Feb; 231(1-2):7-14. PubMed ID: 20965577
[TBL] [Abstract][Full Text] [Related]
40. Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice.
Heremans H; Dillen C; Groenen M; Matthys P; Billiau A
Eur Cytokine Netw; 1999 Jun; 10(2):171-80. PubMed ID: 10400823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
